Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.82 USD | -2.29% | +2.71% | -38.06% |
Financials (USD)
Sales 2024 * | 10.19M | Sales 2025 * | 8.11M | Capitalization | 905M |
---|---|---|---|---|---|
Net income 2024 * | -378M | Net income 2025 * | -403M | EV / Sales 2024 * | 71.5 x |
Net cash position 2024 * | 176M | Net cash position 2025 * | 137M | EV / Sales 2025 * | 94.8 x |
P/E ratio 2024 * |
-2.4
x | P/E ratio 2025 * |
-2.38
x | Employees | 309 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.64% |
Latest transcript on Relay Therapeutics, Inc.
1 day | -2.29% | ||
1 week | +2.71% | ||
Current month | +4.60% | ||
1 month | +10.80% | ||
3 months | -31.80% | ||
6 months | -15.70% | ||
Current year | -38.06% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjiv Patel
CEO | Chief Executive Officer | 50 | 17-02-28 |
Mark Murcko
FOU | Founder | 64 | 15-05-03 |
Alexis Borisy
FOU | Founder | 52 | 15-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Ingram
BRD | Director/Board Member | 61 | 19-05-31 |
Linda Hill
BRD | Director/Board Member | 67 | 18-10-08 |
Jami Rubin
BRD | Director/Board Member | 60 | 19-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 0 M€ | 0.00% | - | |
0.12% | 2 M€ | -.--% | ||
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 6.82 | -2.29% | 653,511 |
24-05-23 | 6.98 | -7.30% | 1,332,658 |
24-05-22 | 7.53 | -0.40% | 1,281,904 |
24-05-21 | 7.56 | +11.50% | 1,448,533 |
24-05-20 | 6.78 | +2.11% | 2,341,965 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.06% | 905M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- RLAY Stock